AUTONOMIX MEDICAL INC (AMIX) Forecast, Price Target & Analyst Ratings

NASDAQ:AMIX • US05330T2050

0.416 USD
0 (-0.17%)
Last: Mar 6, 2026, 09:30 AM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AUTONOMIX MEDICAL INC (AMIX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.20
+ 1,150.48% Upside

Next Earnings Forecast

Earnings Estimate
Release DateN/A
PeriodQ4 / 2026
EPS Estimate-$0.52
Revenue Estimate

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.20
Upside
+ 1,150.48%
From current price of $0.42 to mean target of $5.20, Based on 8 analyst forecasts
Low
$2.02
Median
$5.20
High
$8.61

Price Target Revisions

1 Month
-22.73%
3 Months
-22.73%

Price Target Summary

8 analysts have analysed AMIX and the average price target is 5.2 USD. This implies a price increase of 1150.48% is expected in the next year compared to the current price of 0.416.
The average price target has been revised downward by 22.73% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

AMIX Current Analyst RatingAMIX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

AMIX Historical Analyst RatingsAMIX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
AMIX was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about AMIX.
In the previous month the buy percentage consensus was at a similar level.
AMIX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-17Maxim GroupMaintains Buy -> Buy
2025-04-29Maxim GroupInitiate Buy
2024-09-03Ladenburg ThalmannInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateN/A
PeriodQ4 / 2026
EPS Estimate-$0.52
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q71.54%
Number of Analysts4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
AMIX revenue by date.AMIX revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
AMIX ebitda by date.AMIX ebitda by date.
N/AN/A-11.949M-11.405M
4.55%
N/AN/AN/A
EBIT
YoY % growth
AMIX ebit by date.AMIX ebit by date.
-13.594M-1.991M
85.36%
-12.03M
-504.37%
-11.588M
3.67%
N/A
-36.45%
N/A
2.81%
N/A
-7.99%
Operating Margin
AMIX operating margin by date.AMIX operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AMIX eps by date.AMIX eps by date.
N/AN/AN/AN/AN/A
-77.46%
N/A
30.56%
N/A
-16.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
-0.52
71.54%
-0.45
58.06%
-0.61
55.65%
-0.57
-58.67%
-0.57
-11.29%
-0.48
-6.82%
-0.51
16.67%
-0.51
10.71%
-0.57
0.36%
Revenue
Q2Q % growth
102K255K561K
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-3.435M
-5.62%
-3.921M
-14.63%
3.641M
148.33%
-3.713M
-9.57%
-4.029M
-17.30%
-3.835M
2.20%
-4.09M
-212.34%
-4.08M
-9.89%
-4.59M
-13.92%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AMIX Yearly Revenue VS EstimatesAMIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 200K 400K 600K 800K
AMIX Yearly EPS VS EstimatesAMIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-12.65%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AUTONOMIX MEDICAL INC / AMIX Forecast FAQ

What do analysts expect the price target to be for AUTONOMIX MEDICAL INC (AMIX)?

8 analysts have analysed AMIX and the average price target is 5.2 USD. This implies a price increase of 1150.48% is expected in the next year compared to the current price of 0.416.


What are the consensus estimates for AMIX stock next earnings?

The consensus EPS estimate for the next earnings of AUTONOMIX MEDICAL INC (AMIX) is -0.52 USD and the consensus revenue estimate is 0 USD.


What is the number of analysts for AMIX stock?

The number of analysts covering AUTONOMIX MEDICAL INC (AMIX) is 8.